Company
Lumos Pharma
Lumos Pharma is a clinical stage, biopharmaceutical company developing therapeutics for rare diseases.
Also known as Lumos Pharma, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Lumos Pharma, Inc.
- lumos-pharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Lumos Pharma is a clinical-stage biopharmaceutical company whose mission is to develop new therapies for people with rare diseases, prioritizing its focus where the medical need is high, and the pathophysiology is clear.
Funding snapshot
- Total raised
- $47MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $34M2016-04-04
Funding rounds
- Round, 2016
- $34M2016-04-04, SEC form D sold, 6 investors
- Round, 2014
- $13M2014-01-24, SEC form D sold, 5 investors
Products
- Other
- LUM-201
Loading relationship preview